Research & Development

Investing in technology to remain a leading player.

Each of our Manufacturing Facilities are equipped with an R&D department which are focused on developing new products and processes, improving our existing production processes, adoption of cleaner technology, expanding capabilities to add new chemistries and improving the quality of our existing products coupled with material and cost efficiency. The R&D team is led by Dr. Hemang Desai, our Whole Time Director, who has more than 13 years of R&D, and projects execution experience in the chemicals industry. With a view to further strengthen our R&D capabilities, we continuously recruit and appoint individuals with varied experience and expertise at our R&D facilities with an objective to successfully implement our strategy of early identification of development and manufacturing opportunities. Our R&D team has successfully carried out complex and multi-step unit operations and processes for several molecules and as a result expanded our commercialised product portfolio.
Our R&D laboratories are equipped with sophisticated instruments which include lab high pressure autoclave reactors and high vac distillation units. Our R&D facilities are dedicated to the development of our pipeline and next generation products as well as for our contract manufacturing customers.
Chemical companies usually have a single or a couple of chemistry competencies for their entire product portfolio (Source: F&S Report), however, we are one of the few specialty chemical intermediates companies which has competencies in handling complex reactions including more than 15 chemistries and up to 15 multi-step unit operations and processes..
Over the years, we have invested in R&D and technology enabling us to develop expertise in handling complex chemistries and have successfully commercialized products requiring up to 15 stage unit operations and reactions and have established leadership involving complex and multi-step unit operations and processes (Source: F&S Report). According to the F&S Report, our expertise in complex, hazardous and 15 multi-step unit operations and processes is well poised to benefit from underlying market drivers, both in terms of demand and supply. Our focus on process improvement with regular process audits and reviews, together with output driven R&D processes has resulted in our product portfolio expanding from 102 products in Fiscal 2023 to 135 products in Fiscal 2025. 
We are associated with the Centre of Excellence Unit, Vapi and we can utilize the testing and pilot plant facilities for carrying out any new product developments and trials. We also intend to expand the capacity of our R&D department by setting up a modern  R&D department at our new manufacturing facility in Vapi, Gujarat. The information on our proposed expansion plans is indicative and remain subject to the potential problems and uncertainties.
We believe that our competencies in a large number of chemistries, our expertise in handling complex multi-step unit operations and processes, R&D processes and focus on innovation are key reasons for our success in manufacturing specialty chemical intermediates.